Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 3 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 3 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 hours agoIt will cost $3.5 million for a one-time treatment. And European regulators gave Pfizer the nod for...
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 3 days agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
Clinical Trials Arena via Yahoo Finance· 2 days agoUnder a separate deal forged in October 2023, BioNTech paid Medilink $70m upfront in a deal that...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 3 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 3 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 1 week agoand advance public health.” The mRNA-1083 jab matched or bettered current flu jabs at making the...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 3 days agoAlso Read: European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech.
US FDA puts partial clinical hold on BioNTech’s early-stage study of cancer drug
WSAU Wausau· 3 days ago(Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug...